Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer

This publication has 9 references indexed in Scilit:

• Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group.
  Journal of Clinical Oncology, 1993
• “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
  European Journal of Cancer and Clinical Oncology, 1991
• In vivo manipulation of human breast cancer growth by estrogens and growth hormone: Kinetic and clinical results
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• A design for phase II testing of anticancer agents within a phase III clinical trial
  Controlled Clinical Trials, 1988
• Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
  Journal of Clinical Oncology, 1987
• Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol
  British Journal of Cancer, 1985
• Complete Responders to Chemotherapy in Metastatic Breast Cancer
  JAMA, 1979
• The cell kinetics of human mammary cancers
  Cancer, 1979
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958